Board Members

Mr. Andrew Newell, Non Executive Chairman

Mr. Andrew Newell, Non Executive Chairman

Andrew is the Managing Director of Cipher Surgical Ltd, a surgical technology development company. He has worked in the investment industry and venture capital for 28 years, latterly as a specialist in technology and intellectual property, and now in medical technology. Most recently he was Managing Director of Exomedica, the medical technology developer, and before that an Investment Director for Proven Private Equity and a partner of Media Ventures Partners, both leading venture capital investors with demonstrable success in delivering value to shareholders. A graduate of Magdalen College, Oxford and the London Business School, Andrew had a previous career in investment for Oppenheimer, Enskilda Securities and Fidelity International.

Mr. Sameer Kothari, Chief Executive Director

Mr. Sameer Kothari, Chief Executive Director
Sameer brings over 15 years commercial experience to Zilico. Prior to joining in November 2007 Sameer was CEO of Plasso Technology Ltd, a venture capital-backed company developing research tools and labware for the life sciences. 2007 saw the launch of its first product, EpranEx, a new generation research tool for life scientists. In May 2007, Sameer successfully led a trade sale exit of Plasso to Becton Dickinson Inc.. Prior to joining Plasso, Sameer was a senior executive, with roles in strategy, business development, HR and M&A within Marconi plc. Including a management board position within mainland Europe.

Mr. Steven Couldwell, Non Executive Director

Mr. Steven Couldwell, Non Executive Director

With over 20 years of senior management experience, Steve Couldwell is currently Chief Executive Officer for Tissue Regenix Group. He has a proven international track record in driving revenues and profit growth in both the medical device and CRO industries. Former roles include Global Head and GM for Sanofi Biosurgery, a division of Sanofi and Vice President and General Manager of Covance Laboratories Europe. Steve worked for Smith & Nephew for almost 20 years in a number of roles including President Orthopaedics (Europe) and Senior VP Sales and Marketing for Smith & Nephew’s Advanced Wound Management business.

Dr. Savvas Neophytou, Non Executive Director

Dr. Savvas Neophytou, Non Executive Director

Savvas Neophytou is a partner of Deepbridge Capital LLP primarily focusing on Life Sciences investments. Savvas also co-founded Acorn Partners, a joint venture between Deepbridge Capital, Alder Hey Hospital and software engineers WeAreNova. He is a founding shareholder of a number of technology companies including Torafugu Tech and Cerneretec. Torafugu is engaged in the emerging field of data driven enablers to improve health outcomes and Cerneretec is engaged in the development of point of care diagnostics for the acute care hospital setting. He has also been one of the original team and CEO of Now Healthcare Group, with the online doctor platform Dr Now. Prior to that Savvas had a long career in the City, working for 15 years as an investment banker and ECM at JP Morgan, Bear Stearns, Shore Capital, Cantor Fitzgerald and Panmure Gordon. Sav holds a PhD in psychopharmacology from Nottingham University and a BSc (Hons) degree in pharmacology from Manchester University.

Dr. Alan Folwell, Non Executive Director

Dr. Alan Folwell, Non Executive Director

Alan has exceptional business experience following a range of senior roles in manufacturing and technology-based industries. His leadership experience encompasses a range of sectors from aerospace to carpets, and has always had a major international content. Alan's particular interests are in fostering, growing and developing technology and knowledge-based activities. Alan was also the first chief executive of the Central Technology Belt, to which he now acts as special adviser. A chartered engineer by training, he also has a degree and doctorate from Cambridge University where he was also a double rugby Blue.

Mr Jerry Mobbs, Non Executive Director

Mr Jerry Mobbs

Jerry Mobbs is a Portfolio Director at Spark Impact and is responsible for companies invested in by the firm. Most recently he worked with Finance Wales having spent many years with Merseyside Special Investment Fund, following five years with a regional venture capital fund in Yorkshire. Previously, he was an Investment Executive with 3i plc, following several years working in industry. Jerry has over 25 years' experience of investing in, managing and exiting investments in SMEs across the North of England and Wales. He holds an M.B.A. from the London Business School and graduated from London University.

Tony Miao, Non Executive Director

Tony Maio smiling

Tony (Feng Dong) Miao is the co-founder and CEO of Maxhealth Medicine Group Co. Ltd. A sales and investment company specialising in bringing innovative medical technologies into China, the company is headquartered in Wuxi with a mix of expertise ranging from market access to sales and marketing. Tony holds an E.M.B.A. from Fudan University and prior to his current role within Maxhealth, practiced as a neurosurgeon and is also a qualified plastic surgeon.